Table 1 Clinical characteristics and anamnestic data of the included patients (n = 73).

From: Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia

 

No recurrence

Recurrence

Total

N (%)

N (%)

N (%)

Patients

40 (55)

33 (45)

73 (100)

Age

Mean, median, (range)

61, 62 (35–80)

60, 60 (31–81)

61, 61 (35–81)

Sex

Male

19 (48)

20 (61)

39 (53)

Female

21 (52)

13 (39)

34 (47)

Site of lesion

Floor of the mouth

0 (0)

2 (6)

2 (3)

Buccal mucosa

7 (18)

3 (9)

10 (14)

Lateral tongue

6 (15)

10 (30)

16 (22)

Ventral tongue

5 (13)

1 (3)

6 (8)

Dorsum tongue

0 (0)

1 (3)

1 (1)

Soft palate

1 (3)

0 (0)

1 (1)

Hard palate

5 (13)

3 (9)

8 (11)

Mandibular alveolar gingiva

9 (23)

7 (22)

16 (22)

Maxillary alveolar gingiva

5 (13)

5 (15)

10 (14)

Lip

2 (5)

1 (3)

3 (4)

Clinical diagnosis

Homogenous

29 (73)

14 (48)

43 (59)

Non-homogenous

11 (28)

19 (52)

30 (41)

Size

≥ 200 mm2

10 (25)

14 (42)

24 (33)

< 200 mm2

30 (75)

19 (58)

49 (67)

Dysplasia

Yes

6 (15)

8 (24)

14 (19)

No

34 (85)

25 (76)

59 (81)

Multiple lesions

Yes

19 (48)

22 (67)

41 (56)

No

21 (52)

11 (33)

32 (44)

Smokers

Yes

8 (20)

5 (15)

13 (18)

No

32 (80)

28 (85)

60 (82)

Smokers in the past

Yes

5 (12)

17 (52)

22 (30)

No

32 (80)

14 (42)

46 (63)

No data

3 (8)

2 (6)

5 (7)

Snuff users

Yes

1 (3)

6 (18)

7 (10)

No

39 (97)

27 (82)

66 (90)

Snuff users in the past

Yes

5 (12)

3 (9)

8 (11)

No

32 (80)

23 (70)

55 (75)

No data

3 (8)

7 (21)

10 (14)

Alcohol consumption

Alcohol daily

0 (0)

1 (3)

1 (1)

Several times per week

4 (10)

4 (12)

8 (11)

Once a week

12 (30)

12 (36)

24 (33)

Rarely/never

19 (48)

13 (40)

32 (44)

Never

0 (0)

0 (0)

0 (0)

No data

5 (12)

3 (9)

8 (11)

Cancer transformation

Yes

0 (0)

3 (9)

3 (4)

No

40 (100)

30 (91)

70 (96)